Gastrointestinal Stromal Tumor
📧 Sign up to get email alerts when something new happens for Gastrointestinal Stromal Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-08-15Clinical Trial Update: EUS-FNB vs. Single-incision Needle-knife (SINK) Biopsy for Gastrointestinal SELs [Phase 3]
Phase 3 clinical trial comparing EUS-guided fine-needle biopsy versus single-incision needle-knife biopsy for gastrointestinal subepithelial…
-
FDA approval · 2016-08-04FDA Approved: IMATINIB MESYLATE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approval of Teva's Imatinib Mesylate Original Application under ANDA204285 for a generic Imatinib product.
-
CLINICAL_TRIALS research · 2016-07-11Clinical Trial Update: Permission to Collect Blood Over Time for Research
A terminated Stanford clinical trial update describes permission to collect blood samples over time for research in pancreatic cancer and ot…
-
FDA approval · 2016-06-07FDA Approved: STIVARGA — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for Stivarga (regorafenib) submitted by Bayer HealthCare Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Evaluation of Patients With Bulky GIST Using Sunitinib [NA]
Clinical trial evaluating sunitinib in patients with bulky gastrointestinal stromal tumors has been terminated; results were posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST [NA]
This clinical trial update concerns the evaluation of dasatinib for efficacy and safety in patients with refractory metastatic gastrointesti…
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: A Phase 2 Trial of Ponatinib in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor [Phase 2]
Phase 2 clinical trial update evaluating ponatinib in metastatic and/or unresectable gastrointestinal stromal tumor; results were posted in …
-
CLINICAL_TRIALS trial_result · 2016-04-07Clinical Trial Update: A Study of Nilotinib Versus Imatinib in GIST Patients [Phase 3]
Phase 3 trial comparing nilotinib to imatinib in gastrointestinal stromal tumor has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: A Study Evaluating STA-9090 in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST) [Phase 2]
Phase 2 clinical trial evaluating ganetespib (STA-9090) in patients with metastatic and/or unresectable gastrointestinal stromal tumor has c…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST) [Phase 2]
Phase 2 trial evaluating pazopanib for gastrointestinal stromal tumors has completed, reporting efficacy results from the study.
-
CLINICAL_TRIALS trial_result · 2016-02-04Clinical Trial Update: Laparoscopic Resection of Large Gastric Stromal Tumors
The trial evaluated laparoscopic resection for large gastric gastrointestinal stromal tumors and is reported as completed.
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients [Phase 4]
Phase 4 trial evaluating CYP3A4 and CYP1A2 phenotyping to tailor Sunitinib or Erlotinib therapy in cancer patients, including non-small cell…
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: Evaluation of a New EUS-guided Needle (ProCore) Comparing to EUS-TCB Needle (Quick-Core) [NA]
A completed clinical trial evaluating a new EUS-guided ProCore needle versus the Quick-Core needle for gastrointestinal stromal tumors (GIST…
-
FDA approval · 2015-12-03FDA Approved: IMATINIB MESYLATE — Original Application (BluePoint Laboratories)
FDA approved the original application for Imatinib Mesylate from BluePoint Laboratories (ANDA078340), authorizing a generic version of the c…
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. [NA]
Continuation study of sunitinib malate for patients who left a prior sunitinib trial; completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-10-15Clinical Trial Update: Efficacy of Imatinib in Patients With Intermediate-risk Gastrointestinal Stromal Tumor With a High-risk Genomic Grade Index [Phase 3]
A Phase 3 clinical trial update examines the efficacy of imatinib in patients with intermediate-risk gastrointestinal stromal tumor who have…
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST) [Phase 2]
This update reports the completion of a Phase 2 open-label study evaluating the pharmacodynamic effects of BIIB021 in patients with gastroin…
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Quick Skin Sealant in Closure of Surgical Wound After Laparoscopic Surgery [Phase 2]
Phase 2 clinical trial update evaluating Quick Skin Sealant for closure of surgical wounds after laparoscopic surgery. The document lists su…
-
CLINICAL_TRIALS trial_result · 2015-05-01Clinical Trial Update: Safety And Efficacy Study Of Sunitinib Malate In Chinese Patients With Imatinib Resistant Or Intolerant Malignant Gastrointestinal Stromal Tumor [Phase 4]
A Phase 4 clinical trial evaluated the safety and efficacy of sunitinib malate in Chinese patients with imatinib-resistant or intolerant mal…
-
FDA approval · 2015-04-24FDA Approved: SUTENT — Supplemental Application (U.S. Pharmaceuticals)
FDA approved a supplemental application for Sutent (sunitinib malate) submitted by U.S. Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2015-04-24Clinical Trial Update: Continuation of Drug Supply in Chinese Patients After CAMN107DBR01study Termination
Clinical trial update noting continuation of drug supply for Chinese patients after termination of CAMN107DBR01 in Gastrointestinal Stromal …
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood [Phase 2]
Phase 2 trial of imatinib mesylate in relapsed or refractory pediatric solid tumors has been completed.
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle [NA]
Clinical trial comparing EUS-FNA to EUS-FNB with a novel core biopsy needle in pancreatic cancer and related conditions; completed with resu…
-
CLINICAL_TRIALS trial_result · 2015-02-25Clinical Trial Update: A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients [Phase 2]
Phase 2 clinical trial evaluating AUY922 for Gastrointestinal Stromal Tumor is referenced, with the study sponsored by the National Health R…
-
CLINICAL_TRIALS trial_result · 2015-02-03Clinical Trial Update: Perioperative Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor [Phase 2]
Phase 2 clinical trial evaluating perioperative imatinib mesylate for locally advanced gastrointestinal stromal tumor in patients. The study…